The AHA, Federation of American Hospitals, and American Society of Health-System Pharmacists today convened a panel of experts on Capitol Hill to discuss how continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and staffing investments and identify alternative therapies.
 
Kathleen Pawlicki, vice president and chief pharmacist of Beaumont Health in Michigan and president-elect of ASHP, said the cost of staff time and resources in determining and planning contingencies for these shortages is “astronomical.” Beaumont uses the equivalent of six full-time staff – or 12,000 hours per year – to manage and monitor drug shortages.
 
The panel, which included Martin VanTrieste, president and CEO of Civica Rx – a not-for-profit generic drug company established last year by several hospitals and health systems to address shortages and high prices of medications; Jack Hoadley, research professor emeritus at Georgetown University’s Health Policy Institute; Molly Smith, AHA vice president for coverage and state issues; and Erik Rasmussen, AHA vice president of federal relations; discussed findings from a recent report prepared by NORC at the University of Chicago for the AHA, FAH and ASHP.
 
Among other findings, the report showed that average total drug spending per hospital admission increased by 18.5 percent between fiscal years 2015 and 2017, including increases in some drug classes of more than 80 percent and exceeding the Medicare payment update by fivefold.
 
To restrain out-of-control drug prices, the AHA has recommended several solutions, including stopping brand-name manufacturers' anticompetitive actions by addressing ever-greening and pay-for-delay practices, speeding up generic drug approvals, and passing the CREATES Act.

Related News Articles

Headline
The AHA today submitted comments on the revised version of the Lower Health Care Costs Act (S. 1895), legislation to prevent surprise medical bills, reduce…
Headline
Sens. Lamar Alexander, R-Tenn., and Patty Murray, D-Wash., today introduced the Lower Health Care Costs Act (S.1895), legislation to prevent surprise medical…
Headline
The Senate Committee on Health, Education, Labor and Pensions today held a hearing on the Lower Health Care Costs Act, its draft legislation to prevent…
Headline
In an evaluation of 49 top-selling brand-name drugs, 28 of the drugs available since 2012 saw an increase in insurer and out-of-pocket costs of more than 50…
Headline
Ways and Means Committee Chairman Richard Neal, D-Mass., and Energy and Commerce Committee Chairman Frank Pallone Jr., D-N.J., along with Ranking Members Kevin…
Headline
The House Energy and Commerce Subcommittee on Health today held a hearing on seven bills aimed at improving transparency in the drug supply chain to lower…